ReportWire

Tag: DaVita

  • Colorado man raising awareness, hope as he waits for second kidney transplant

    [ad_1]

    LITTLETON, Colo. — A Colorado man is raising awareness and hope as he waits for a second kidney transplant.

    Facing polycystic kidney disease, a genetic form of the disease, Rick Mendoza received a kidney transplant from his sister-in-law in 2011. He said it made him feel “fully alive” and allowed him to be present for his daughter’s formative years.

    “She probably didn’t want me on the sidelines as much during her soccer games, but I was there supporting her and cheering her,” he told Denver7.

    Mendoza family

    But just over a decade later, in 2022, Mendoza became sick again.

    “You feel like your energy level, you had no longer the energy to do things,” he explained. “With kidney failure, your red blood cells take away the oxygen that goes throughout your body, so you feel anemic, and then there’s nausea.”

    It turns out his donated kidney was failing “abruptly.” He went back on a transplant wait list, which can take several years on average. He also went back to dialysis treatments, which can take a toll.

    Chronic kidney disease gradually damages the kidneys, making it harder for them to filter waste or excess fluid out of the blood, leading to serious health problems.

    Rick Mendoza

    Mendoza family

    Joseph Garcia is a group regional operations director with DaVita, a Denver-based company with dialysis centers across the country. He said patients typically are treated multiple times a week, “anywhere from three and a half to four-plus hours.”

    “About half of our patients who end up on dialysis services, meaning their kidneys failed, crash into it, meaning they had no idea that their kidneys were at risk,” Garcia told Denver7.

    That underscores findings from the National Kidney Foundation that one in seven U.S. adults has chronic kidney disease, but 90 percent of them don’t realize they have it because symptoms can be mild or non-existent at first.

    Rick Mendoza and his family spread kidney disease awareness at the Denver Kidney Walk.

    Mendoza family

    Rick Mendoza and his family spread kidney disease awareness at the Denver Kidney Walk.

    Mendoza now volunteers with the National Kidney Foundation to raise awareness.

    “I think this time around, I felt that I needed to do something more than just looking out for myself,” he explained. “I think there are others that are less fortunate than me.”

    Those with high blood pressure or diabetes are especially at risk for kidney disease. Garcia and kidney health advocates encourage regular doctor visits, as well as blood or urine exams.

    “I think the biggest thing I would encourage people to do is proactive screenings, proactive conversations,” Garcia told Denver7.

    A healthy diet and exercise, they say, can also promote good kidney health, something Mendoza embodies even while going through dialysis treatments.

    “The next day [after treatment], I feel, you know, that I can do a lot of things, like golf. I work full-time,” he explained.

    Rick Mendoza

    Mendoza family

    Garcia praised Mendoza for his mindset amid the struggles.

    “He’s amazing,” Garcia said. “When you think about his journey with his kidney health and how he just has a positive attitude, he lives a fully active lifestyle, he’s an ambassador and a champion for other kidney care patients. It’s a privilege to work with him.”

    Mendoza is not waiting to live, even as he waits for another donor.

    “I’m hoping that day comes,” he said. “But until then, and after then, I just want to do more, and I feel like I do more with what I have to offer.”

    Denver7 is a proud sponsor of the Denver Kidney Walk. Anchor/reporter Ryan Fish will emcee the event on Sunday, Oct. 5, at Great Lawn Park in Denver.

    ryan image bar.jpg

    Denver7 | Your Voice: Get in touch with Ryan Fish

    Denver7’s Ryan Fish covers stories that have an impact in all of Colorado’s communities, but specializes in covering artificial intelligence, technology, aviation and space. If you’d like to get in touch with Ryan, fill out the form below to send him an email.

    [ad_2]

    Ryan Fish

    Source link

  • DaVita Inc. (NYSE:DVA) Shares Acquired by DekaBank Deutsche Girozentrale

    DaVita Inc. (NYSE:DVA) Shares Acquired by DekaBank Deutsche Girozentrale

    [ad_1]

    DekaBank Deutsche Girozentrale boosted its position in DaVita Inc. (NYSE:DVAFree Report) by 19.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,130 shares of the company’s stock after acquiring an additional 1,463 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in DaVita were worth $877,000 at the end of the most recent quarter.

    Other hedge funds have also recently added to or reduced their stakes in the company. Resources Management Corp CT ADV raised its holdings in DaVita by 5,900.0% in the second quarter. Resources Management Corp CT ADV now owns 300 shares of the company’s stock valued at $30,000 after acquiring an additional 295 shares in the last quarter. Harbor Investment Advisory LLC acquired a new stake in DaVita in the third quarter valued at approximately $34,000. Parkside Financial Bank & Trust raised its holdings in DaVita by 88.6% in the first quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock valued at $35,000 after acquiring an additional 147 shares in the last quarter. Penserra Capital Management LLC acquired a new stake in DaVita in the second quarter valued at approximately $36,000. Finally, FinTrust Capital Advisors LLC raised its holdings in DaVita by 242.3% in the third quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock valued at $67,000 after acquiring an additional 504 shares in the last quarter. Institutional investors and hedge funds own 84.69% of the company’s stock.

    Insider Buying and Selling

    In related news, insider James O. Hearty sold 26,164 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $119.64, for a total transaction of $3,130,260.96. Following the completion of the sale, the insider now directly owns 20,264 shares of the company’s stock, valued at $2,424,384.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Kathleen Alyce Waters sold 11,285 shares of the stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $120.73, for a total transaction of $1,362,438.05. Following the completion of the sale, the insider now directly owns 81,297 shares of the company’s stock, valued at $9,814,986.81. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider James O. Hearty sold 26,164 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the sale, the insider now directly owns 20,264 shares of the company’s stock, valued at $2,424,384.96. The disclosure for this sale can be found here. Insiders sold a total of 66,937 shares of company stock valued at $8,025,656 over the last three months. 1.40% of the stock is currently owned by company insiders.

    DaVita Stock Performance

    Shares of DVA opened at $125.25 on Friday. The company has a current ratio of 1.19, a quick ratio of 1.13 and a debt-to-equity ratio of 6.65. The firm has a market cap of $10.98 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 1.10 and a beta of 1.00. The company’s 50 day simple moving average is $109.82 and its 200-day simple moving average is $100.07. DaVita Inc. has a 12-month low of $71.51 and a 12-month high of $128.28.

    DaVita (NYSE:DVAGet Free Report) last announced its earnings results on Tuesday, February 13th. The company reported $1.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.53 by $0.34. The business had revenue of $3.15 billion for the quarter, compared to analyst estimates of $3.01 billion. DaVita had a net margin of 5.70% and a return on equity of 64.42%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $1.11 earnings per share. As a group, equities analysts predict that DaVita Inc. will post 9.23 EPS for the current year.

    Analyst Upgrades and Downgrades

    Several equities analysts have commented on the stock. UBS Group increased their price target on shares of DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. Truist Financial increased their price target on shares of DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a research note on Tuesday. StockNews.com lowered shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. Finally, TheStreet upgraded shares of DaVita from a “c+” rating to a “b-” rating in a research note on Wednesday, February 7th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, DaVita presently has a consensus rating of “Moderate Buy” and an average price target of $115.60.

    Check Out Our Latest Stock Analysis on DVA

    DaVita Profile

    (Free Report)

    DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

    See Also

    Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

    Institutional Ownership by Quarter for DaVita (NYSE:DVA)

    Receive News & Ratings for DaVita Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DaVita and related companies with MarketBeat.com’s FREE daily email newsletter.

    [ad_2]

    ABMN Staff

    Source link